Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Aine Carol Burke, Ronan T Swords, Kevin Kelly & Francis J Giles. (2011) Current status of agents active against the T315I chronic myeloid leukemia phenotype. Expert Opinion on Emerging Drugs 16:1, pages 85-103.
Read now
Read now
Articles from other publishers (17)
Yuting Wang, Mingyao He, Xiang Li, Jinlong Chai, Qinglin Jiang, Cheng Peng, Gu He & Wei Huang. (2021) Design, Synthesis, and Biological Evaluation of Pyrano[2,3-c]-pyrazole–Based RalA Inhibitors Against Hepatocellular Carcinoma. Frontiers in Chemistry 9.
Crossref
Crossref
Jing-Dong Zhou, Dong-Ming Yao, Xi-Xi Li, Ting-Juan Zhang, Wei Zhang, Ji-Chun Ma, Hong Guo, Zhao-Qun Deng, Jiang Lin & Jun Qian. (2017)
KRAS
overexpression independent of
RAS
mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia
. Oncotarget 8:39, pages 66087-66097.
Crossref
Crossref
Ivelina Jelezova, Elena Drakalska, Denitsa Momekova, Natalia Shalimova, Georgi Momekov, Spiro Konstantinov, Stanislav Rangelov & Stergios Pispas. (2015) Curcumin loaded pH-sensitive hybrid lipid/block copolymer nanosized drug delivery systems. European Journal of Pharmaceutical Sciences 78, pages 67-78.
Crossref
Crossref
Michele Caraglia, Giovanni Francesco Nicoletti, Angela Lombardi, Gerardo Botti & Renato Franco. 2014. Skin Cancer. Skin Cancer
29
57
.
Heather Male, Vijay Patel, Mark A. Jacob, Emma Borrego-Diaz, Kun Wang, Derek A. Young, Amanda L. Wise, Chao Huang, Peter Van Veldhuizen, Amy O’Brien-Ladner, Stephen K. Williamson, Sarah A. Taylor, Ossama Tawfik, Tuba Esfandyari & Faris Farassati. (2012) Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer. Lung Cancer 77:2, pages 252-259.
Crossref
Crossref
Kun Wang, Vidya Bodempudi, Zhengian Liu, Emma Borrego-Diaz, Farnaz Yamoutpoor, Anna Meyer, Richard A. Woo, Weihong Pan, Arkadiusz Z. Dudek, Mojtaba S. Olyaee, Tuba Esfandyari & Faris Farassati. (2012) Inhibition of Mesothelin as a Novel Strategy for Targeting Cancer Cells. PLoS ONE 7:4, pages e33214.
Crossref
Crossref
Faris Farassati. 2012. Neurofibromatosis Type 1. Neurofibromatosis Type 1
589
609
.
Bi-Dar Wang, Christina Leah B. Kline, Danielle M. Pastor, Thomas L. Olson, Bryan Frank, Truong Luu, Arun K. Sharma, Gavin Robertson, Matthew T. Weirauch, Steven R. Patierno, Joshua M. Stuart, Rosalyn B. Irby & Norman H. Lee. (2010) Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NFκB and microRNA network. Molecular Cancer 9:1.
Crossref
Crossref
Roberta R. Ruela-de-Sousa, Karla C.S. Queiroz, Maikel P. Peppelenbosch & Gwenny M. Fuhler. (2010) Reversible phosphorylation in haematological malignancies: Potential role for protein tyrosine phosphatases in treatment?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1806:2, pages 287-303.
Crossref
Crossref
Shozo Yoshida, Naoto Furukawa, Shoji Haruta, Yasuhito Tanase, Seiji Kanayama, Taketoshi Noguchi, Mariko Sakata, Yoshihiko Yamada, Hidekazu Oi & Hiroshi Kobayashi. (2009) Theoretical model of treatment strategies for clear cell carcinoma of the ovary: Focus on perspectives. Cancer Treatment Reviews 35:7, pages 608-615.
Crossref
Crossref
Weihong Pan, Vidya Bodempudi, Tuba Esfandyari & Faris Farassati. (2009) Utilizing Ras Signaling Pathway to Direct Selective Replication of Herpes Simplex Virus-1. PLoS ONE 4:8, pages e6514.
Crossref
Crossref
Ibrahim F. Benter, Halit Canatan, Mustapha Benboubetra, Mariam H.M. Yousif & Saghir Akhtar. (2009) Global upregulation of gene expression associated with renal dysfunction in DOCA–salt-induced hypertensive rats occurs via signaling cascades involving epidermal growth factor receptor: A microarray analysis. Vascular Pharmacology 51:2-3, pages 101-109.
Crossref
Crossref
Amit Thakkar, Allison S. Cohen, Michael D. Connolly, Ronald N. Zuckermann & Dehua Pei. (2009) High-Throughput Sequencing of Peptoids and Peptide−Peptoid Hybrids by Partial Edman Degradation and Mass Spectrometry. Journal of Combinatorial Chemistry 11:2, pages 294-302.
Crossref
Crossref
Brian Van Ness, Christine Ramos, Majda Haznadar, Antje Hoering, Jeff Haessler, John Crowley, Susanna Jacobus, Martin Oken, Vincent Rajkumar, Philip Greipp, Bart Barlogie, Brian Durie, Michael Katz, Gowtham Atluri, Gang Fang, Rohit Gupta, Michael Steinbach, Vipin Kumar, Richard Mushlin, David Johnson & Gareth Morgan. (2008) Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival. BMC Medicine 6:1.
Crossref
Crossref
Mariam H.M. Yousif, Ibrahim F. Benter, Ahmed H.T. Abul, Saju Abraham, Thomas Walther & Saghir Akhtar. (2008) Inhibition of Ras-GTPase signaling by FPTIII ameliorates development of cardiovascular dysfunction in diabetic–hypertensive rats. Vascular Pharmacology 49:4-6, pages 151-157.
Crossref
Crossref
A Quintás-Cardama. (2008) Experimental non-ATP-competitive therapies for chronic myelogenous leukemia. Leukemia 22:5, pages 932-940.
Crossref
Crossref
Elke Burgermeister & Rony Seger. (2008)
PPAR
and MEK Interactions in Cancer
. PPAR Research 2008, pages 1-16.
Crossref
Crossref